Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial

Nicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, Pierre Van Damme, Adolfo Garcı́a-Sastre, Florian Krammer, Raffael Nachbagauer, Peter Palese, Alicia Solórzano, Dan Bi, Marie‐Pierre David, Damien Friel, Bruce L. Innis, Juliane Koch, Corey P. Mallett, Ronan Rouxel, Bruno Salaun, Valérie Vantomme, Céline Verheust, Frank Struyf